Optionsscheine finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
898 Ergebnisse
| GW8Q5K | Regeneron Pharmaceuticals Inc./OS/Call [500]/GOLDS | - | - | 500,000 | call | Regeneron Pharmaceuticals Inc. | - | 46,277 % | 0,805 | -0,006 | 2,046 | 16.06.2028 | 0,010 | Goldman Sachs | ||
| MK9KF7 |  | Regeneron Pharmaceuticals Inc./OS/Call [500]/MS | - | - | 500,000 | call | Regeneron Pharmaceuticals Inc. | - | 50,082 % | 0,822 | -0,010 | 2,422 | 17.06.2027 | 0,010 | Morgan Stanley | |
| MR08LU | | Regeneron Pharmaceuticals Inc./OS/Call [500]/MS | - | - | 500,000 | call | Regeneron Pharmaceuticals Inc. | 550,000 | 13,499 % | - | - | - | 19.03.2027 | 0,100 | Morgan Stanley | |
| MR08LV | | Regeneron Pharmaceuticals Inc./OS/Call [500]/MS | - | - | 500,000 | call | Regeneron Pharmaceuticals Inc. | 550,000 | - | - | - | - | 18.12.2026 | 0,100 | Morgan Stanley | |
| FA53HM | Regeneron Pharmaceuticals Inc./OS/Call [500]/SOC | - | - | 500,000 | call | Regeneron Pharmaceuticals Inc. | - | - | 1,000 | 0,000 | 3,867 | 18.12.2026 | 0,100 | Société Générale | ||
| FA6MCS | Regeneron Pharmaceuticals Inc./OS/Call [500]/SOC | - | - | 500,000 | call | Regeneron Pharmaceuticals Inc. | - | - | 1,000 | 0,000 | 3,904 | 18.09.2026 | 0,100 | Société Générale | ||
| JH5XQV | Regeneron Pharmaceuticals Inc./OS/Call [510]/JPM | - | - | 510,000 | call | Regeneron Pharmaceuticals Inc. | - | 42,317 % | 0,888 | -0,010 | 3,264 | 18.12.2026 | 0,010 | JP Morgan | ||
| MK9KF8 | | Regeneron Pharmaceuticals Inc./OS/Call [525]/MS | - | - | 525,000 | call | Regeneron Pharmaceuticals Inc. | - | 48,111 % | 0,799 | -0,010 | 2,571 | 17.06.2027 | 0,010 | Morgan Stanley | |
| JH5SJD | Regeneron Pharmaceuticals Inc./OS/Call [540]/JPM | - | - | 540,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,021 % | 0,849 | -0,011 | 3,612 | 18.12.2026 | 0,010 | JP Morgan | ||
| PG10X1 | | Regeneron Pharmaceuticals Inc./OS/Call [550]/BNP | - | - | 550,000 | call | Regeneron Pharmaceuticals Inc. | - | 42,883 % | 0,826 | -0,012 | 3,625 | 18.12.2026 | 0,010 | BNP Paribas | |
| PG10X6 | | Regeneron Pharmaceuticals Inc./OS/Call [550]/BNP | - | - | 550,000 | call | Regeneron Pharmaceuticals Inc. | - | 42,992 % | 0,814 | -0,012 | 3,446 | 15.01.2027 | 0,010 | BNP Paribas | |
| PG10XP | | Regeneron Pharmaceuticals Inc./OS/Call [550]/BNP | - | - | 550,000 | call | Regeneron Pharmaceuticals Inc. | - | - | 1,000 | 0,000 | 5,383 | 18.09.2026 | 0,010 | BNP Paribas | |
| PJ912R | | Regeneron Pharmaceuticals Inc./OS/Call [550]/BNP | - | - | 550,000 | call | Regeneron Pharmaceuticals Inc. | - | 43,886 % | 0,793 | -0,011 | 3,112 | 19.03.2027 | 0,010 | BNP Paribas | |
| PM3TMB | | Regeneron Pharmaceuticals Inc./OS/Call [550]/BNP | - | - | 550,000 | call | Regeneron Pharmaceuticals Inc. | - | 45,036 % | 0,777 | -0,010 | 2,774 | 17.06.2027 | 0,010 | BNP Paribas | |
| GW640Z | Regeneron Pharmaceuticals Inc./OS/Call [550]/GOLDS | - | - | 550,000 | call | Regeneron Pharmaceuticals Inc. | - | - | 1,000 | 0,000 | 5,503 | 21.01.2028 | 0,010 | Goldman Sachs | ||
| GW72WS | Regeneron Pharmaceuticals Inc./OS/Call [550]/GOLDS | - | - | 550,000 | call | Regeneron Pharmaceuticals Inc. | - | 45,182 % | 0,765 | -0,008 | 2,358 | 21.01.2028 | 0,010 | Goldman Sachs | ||
| GW7KDL | Regeneron Pharmaceuticals Inc./OS/Call [550]/GOLDS | - | - | 550,000 | call | Regeneron Pharmaceuticals Inc. | - | 43,156 % | 0,792 | -0,011 | 3,153 | 19.03.2027 | 0,010 | Goldman Sachs | ||
| GW7N0M | Regeneron Pharmaceuticals Inc./OS/Call [550]/GOLDS | - | - | 550,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,696 % | 0,818 | -0,012 | 3,508 | 15.01.2027 | 0,010 | Goldman Sachs | ||
| GW92TG | Regeneron Pharmaceuticals Inc./OS/Call [550]/GOLDS | - | - | 550,000 | call | Regeneron Pharmaceuticals Inc. | - | 45,949 % | 0,764 | -0,007 | 2,162 | 16.06.2028 | 0,010 | Goldman Sachs | ||
| GW95G5 | Regeneron Pharmaceuticals Inc./OS/Call [550]/GOLDS | - | - | 550,000 | call | Regeneron Pharmaceuticals Inc. | - | 42,782 % | 0,782 | -0,010 | 2,859 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| JH5C26 | Regeneron Pharmaceuticals Inc./OS/Call [550]/JPM | - | - | 550,000 | call | Regeneron Pharmaceuticals Inc. | - | 44,251 % | 0,898 | -0,014 | 4,504 | 18.09.2026 | 0,010 | JP Morgan | ||
| MK9KF9 | | Regeneron Pharmaceuticals Inc./OS/Call [550]/MS | - | - | 550,000 | call | Regeneron Pharmaceuticals Inc. | - | 47,089 % | 0,772 | -0,010 | 2,705 | 17.06.2027 | 0,010 | Morgan Stanley | |
| MN1W1R | | Regeneron Pharmaceuticals Inc./OS/Call [550]/MS | - | - | 550,000 | call | Regeneron Pharmaceuticals Inc. | 600,000 | 32,175 % | - | - | - | 18.09.2026 | 0,100 | Morgan Stanley | |
| MR08LW | | Regeneron Pharmaceuticals Inc./OS/Call [550]/MS | - | - | 550,000 | call | Regeneron Pharmaceuticals Inc. | 600,000 | 15,565 % | - | - | - | 19.03.2027 | 0,100 | Morgan Stanley | |
| MR08LX | | Regeneron Pharmaceuticals Inc./OS/Call [550]/MS | - | - | 550,000 | call | Regeneron Pharmaceuticals Inc. | 600,000 | 18,830 % | - | - | - | 18.12.2026 | 0,100 | Morgan Stanley | |
| MR3SQ2 | | Regeneron Pharmaceuticals Inc./OS/Call [550]/MS | - | - | 550,000 | call | Regeneron Pharmaceuticals Inc. | 600,000 | 14,239 % | - | - | - | 17.06.2027 | 0,100 | Morgan Stanley | |
| MR3SQ1 | | Regeneron Pharmaceuticals Inc./OS/Call [550]/MS | - | - | 550,000 | call | Regeneron Pharmaceuticals Inc. | 600,000 | 16,780 % | - | - | - | 15.01.2027 | 0,100 | Morgan Stanley | |
| FA6MCT | Regeneron Pharmaceuticals Inc./OS/Call [550]/SOC | - | - | 550,000 | call | Regeneron Pharmaceuticals Inc. | - | - | 1,000 | 0,000 | 5,398 | 18.09.2026 | 0,100 | Société Générale | ||
| FA6MCV | Regeneron Pharmaceuticals Inc./OS/Call [550]/SOC | - | - | 550,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,806 % | 0,830 | -0,119 | 3,674 | 18.12.2026 | 0,100 | Société Générale | ||
| MK9KFA | | Regeneron Pharmaceuticals Inc./OS/Call [575]/MS | - | - | 575,000 | call | Regeneron Pharmaceuticals Inc. | - | 45,830 % | 0,744 | -0,011 | 2,858 | 17.06.2027 | 0,010 | Morgan Stanley | |
| MR0XEE | | Regeneron Pharmaceuticals Inc./OS/Call [575]/MS | - | - | 575,000 | call | Regeneron Pharmaceuticals Inc. | - | 44,963 % | 0,773 | -0,014 | 3,779 | 18.12.2026 | 0,010 | Morgan Stanley | |
| MR0XEF | | Regeneron Pharmaceuticals Inc./OS/Call [575]/MS | - | - | 575,000 | call | Regeneron Pharmaceuticals Inc. | - | 45,036 % | 0,752 | -0,012 | 3,224 | 19.03.2027 | 0,010 | Morgan Stanley | |
| MR16WM | | Regeneron Pharmaceuticals Inc./OS/Call [575]/MS | - | - | 575,000 | call | Regeneron Pharmaceuticals Inc. | - | 51,068 % | 0,735 | -0,009 | 2,302 | 17.12.2027 | 0,010 | Morgan Stanley | |
| GW9CZ0 | Regeneron Pharmaceuticals Inc./OS/Call [580]/GOLDS | - | - | 580,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,890 % | 0,758 | -0,011 | 3,509 | 19.03.2027 | 0,010 | Goldman Sachs | ||
| GW9F6V | Regeneron Pharmaceuticals Inc./OS/Call [590]/GOLDS | - | - | 590,000 | call | Regeneron Pharmaceuticals Inc. | - | 42,134 % | 0,730 | -0,010 | 3,088 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| GW9FC4 | Regeneron Pharmaceuticals Inc./OS/Call [590]/GOLDS | - | - | 590,000 | call | Regeneron Pharmaceuticals Inc. | - | 46,231 % | 0,729 | -0,008 | 2,237 | 16.06.2028 | 0,010 | Goldman Sachs | ||
| GW9FC9 | Regeneron Pharmaceuticals Inc./OS/Call [590]/GOLDS | - | - | 590,000 | call | Regeneron Pharmaceuticals Inc. | - | 44,073 % | 0,725 | -0,008 | 2,509 | 21.01.2028 | 0,010 | Goldman Sachs | ||
| JH37C5 | Regeneron Pharmaceuticals Inc./OS/Call [590]/JPM | - | - | 590,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,433 % | 0,763 | -0,013 | 4,260 | 18.12.2026 | 0,010 | JP Morgan | ||
| PL48EC | | Regeneron Pharmaceuticals Inc./OS/Call [600]/BNP | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,295 % | 0,738 | -0,014 | 4,243 | 18.12.2026 | 0,010 | BNP Paribas | |
| PL69PK | | Regeneron Pharmaceuticals Inc./OS/Call [600]/BNP | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,058 % | 0,732 | -0,014 | 4,009 | 15.01.2027 | 0,010 | BNP Paribas | |
| PL69PJ | | Regeneron Pharmaceuticals Inc./OS/Call [600]/BNP | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,039 % | 0,797 | -0,019 | 5,825 | 18.09.2026 | 0,010 | BNP Paribas | |
| PJ912Q | | Regeneron Pharmaceuticals Inc./OS/Call [600]/BNP | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | - | 42,144 % | 0,720 | -0,012 | 3,528 | 19.03.2027 | 0,010 | BNP Paribas | |
| PM1WLP | | Regeneron Pharmaceuticals Inc./OS/Call [600]/BNP | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | - | 48,088 % | 0,721 | -0,008 | 2,201 | 16.06.2028 | 0,010 | BNP Paribas | |
| PM1WLN | | Regeneron Pharmaceuticals Inc./OS/Call [600]/BNP | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | - | 43,293 % | 0,714 | -0,011 | 3,084 | 17.06.2027 | 0,010 | BNP Paribas | |
| PM2W17 | | Regeneron Pharmaceuticals Inc./OS/Call [600]/BNP | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | - | 46,879 % | 0,715 | -0,009 | 2,435 | 21.01.2028 | 0,010 | BNP Paribas | |
| PM2W16 | | Regeneron Pharmaceuticals Inc./OS/Call [600]/BNP | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | - | 46,815 % | 0,710 | -0,009 | 2,503 | 17.12.2027 | 0,010 | BNP Paribas | |
| PM2W18 | | Regeneron Pharmaceuticals Inc./OS/Call [600]/BNP | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | - | 47,208 % | 0,716 | -0,008 | 2,342 | 17.03.2028 | 0,010 | BNP Paribas | |
| PM5038 | | Regeneron Pharmaceuticals Inc./OS/Call [600]/BNP | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | - | 45,155 % | 0,710 | -0,010 | 2,748 | 17.09.2027 | 0,010 | BNP Paribas | |
| GJ9HLL | Regeneron Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,977 % | 0,745 | -0,014 | 4,409 | 18.12.2026 | 0,010 | Goldman Sachs | ||
| GV70Q7 | Regeneron Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | - | 36,696 % | 0,818 | -0,017 | 6,207 | 18.09.2026 | 0,010 | Goldman Sachs |